IRRAS AB (publ) announced that its Board of Directors has appointed Will Martin as President of the Company. Will Martin, currently the company's President and Chief Commercial Officer, will assume his new role on July 1, 2021, He will succeed current CEO, Kleanthis G. Xanthopoulos, Ph.D., who will remain on IRRAS' Board of Directors and will serve as a company advisor during a transition period. Will Martin joined IRRAS in 2018. Prior to IRRAS, he served as General Manager of the Peripheral Vascular devices business for Philips Healthcare, Vice President of Commercial Operations at AtheroMed Inc. prior to its acquisition by Volcano Corporation, and held other key commercial roles at other life science companies.